InvestorsHub Logo

gburgin

01/05/17 8:57 AM

#86746 RE: Cpoulsen2 #86735

re: "next trigger"
If the company is waiting on resolution of the 2-73+donepezil patent application to determine if the P3 will be for that combo or something else then approval of that patent could be the trigger in terms of P3 partnering and execution. Seems like from yesterday's postings on that patent, the company only needs to provide more dosing information to match the broadness of the claims.